Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adial, Ascentage, Cyclo, Diurnal, Effrx, Hillstream, Pharming, Protagonist, PTC, Roche, TG, Xeris, Zosano.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Affinivax, Biogen, Briacell, Cidara, Crispr, Gilead, Mycovia, Myovant, Onxeo, Pfizer, Trevi, Vir.
New hires and promotions in the biopharma industry, including: Avrobio, Azurrx, Bicycle, Medicinova, Neoleukin, Pharmaessentia, Rheos, Taiwan Liposome, Tempest.
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Direct Biologics, Dr. Reddy’s Laboratories, Edesa, Eisai, Enlivex, Gilead Sciences, Immunitybio, Moderna, Prestige, Recce, Sorrento, Tevogen.